Pawel K. Mazur

Associate Professor, MD Anderson Cancer Center. We are dedicated to identifying novel therapies for lung and pancreatic cancer. Join our team! #mazurforthecure

[Simone Hausmann @Simone_Hausmann]

The MazurLab @MDAndersonNews was walking at the #PanCANPurpleStride #PurpleStrideHouston today to raise awareness for this devastating disease and show support for pancreatic cancer survivors @PanCAN @PancanHouston

[Pawel K. Mazur @MazurLab]

The @Mazurlab walked to today to raise money and awareness for pancreatic cancer at the Purple Stride in Houston #PanCAN #PanCANPurpleStrideHouston

[Pawel K. Mazur @MazurLab]

The @MazurLab at MD Anderson is wearing purple on #WorldPancreaticCancerDay to raise awareness for this devastating disease #PanCANawareness

[Pawel K. Mazur @MazurLab]

The link to the job ad can be found here: https://t.co/mbTmKjLtPY

[Pawel K. Mazur @MazurLab]

The #MazurLab is looking for a research assistant to join a great team of passionate and dedicated researchers. If you are interested in cancer research, want to contribute to our scientific adventures and enjoy being involved in many exciting innovative projects, please apply!

[Simone Hausmann @Simone_Hausmann]

The @MazurLab met early this morning to support pancreatic cancer research at #PanCANPurpleStride in Houston

[Pawel K. Mazur @MazurLab]

Happy Halloween from the Mazur Lab!
#halloween2021

[Julien Sage @SageJulien]

Excited about this publication from star student Andrea Chaikovsky @stanfordcbio on the regulation of Cyclin D levels and the response to Cdk4/6 inhibitors. Close collaboration with many labs, including @LabWinslow, @PetrovADmitri, @cncurtis, @KroganLab... https://t.co/n8UON3BsXo

[Cancer Discovery @CD_AACR]

#ResearchWatch: The histone methyltransferase NSD3 is a lung squamous cell carcinoma driver.
@MazurLab @MDAndersonNews @Stanford #LungCancer #Epigenetics
https://t.co/yT8Uc0fBcy

[Nature Reviews Cancer @NatureRevCancer]

NEW #ResearchHighlight! Research by the teams of Shao, Jaremko, Mazur @MazurLab & Gozani shows that NSD3, which encodes a histone H3 lysine 36 methyltransferase, is likely an important driver of a subset of lung squamous cell carcinomas. 📯 https://t.co/vXXOAQ8iZw

@NatResCancer

[Pawel K. Mazur @MazurLab]

Elevated NSD3 histone methylation activity drives squamous cell lung cancer https://t.co/dhxWQzaegc

[EpiCypher, Inc. @epicypher]

New work from Or Gozani @MazurLab and co. finds that a mutated form of NSD3 results in increased H3K36 methylation and promotes lung cancer development. Also used EpiCypher's pAG-MNase for CUT&RUN assays and our nucleosomes for HMT experiments! #chromatin
https://t.co/ymOQmhbnRe

[PubMed Trending @PubTrend]

Trending on PubMed: Elevated NSD3 histone methylation activity drives squamous cell lung cancer. https://t.co/3vE1Maar5W

[FrezzaLab @FrezzaLab]

Elevated NSD3 histone methylation activity drives squamous cell lung cancer | Nature https://t.co/8HYGSi7PcI

[Nature News & Views @NatureNV]

Hyperactivity of the methyltransferase protein NSD3 drives some cancers https://t.co/XrJholzBdz

[Pulmonary Cell News @pulmonary_news]

Researchers at @Stanford, @MDAndersonNews, @KAUST_News & @UM_1981 showed that elevated NSD3 histone methylation activity drives squamous cell #LungCancer.

📌 @nature
🔗 https://t.co/azj6mWngxy

[Nature News & Views @NatureNV]

The discovery that methyltransferase protein NSD3 drives some cancers opens up new therapeutic opportunities https://t.co/UYTWIyButJ

[Nature News & Views @NatureNV]

Hyperactivity of the methyltransferase protein NSD3 drives some cancers https://t.co/UYTWIyButJ

[Cancer Cell @Cancer_Cell]

SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy https://t.co/zBJrltO7Fv